Drugs / Neuroncell-EX
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT06129175 | Dec 2023 → Nov 2026 expected | ischemic stroke | Cytopeutics Sdn. Bhd. | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Neuroncell-EX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06129175 ↗ |
| Modality | Cell therapy | “Umbilical cord mesenchymal stem cells” NCT06129175 ↗ |
| Route | Intravenous | “Intravenous infusion of Neuroncell-EX” NCT06129175 ↗ |